How Epigenomics Is Transforming Drug Discovery and Development
In this GEN eBook readers will discover how epigenomic insights are improving every stage of the drug discovery pipeline, from target identification and validation to mechanism-of-action studies and therapeutic optimization. The post How Epigenomics Is Transforming Drug Discovery and Development appeared first on GEN - Genetic Engineering and Biotechnology News .
Understanding the role of gene regulation is crucial in contemporary drug discovery. While DNA sequence and RNA expression provide valuable insights, they only scratch the surface of the story. Epigenomic technologies, such as chromatin mapping assays like CUT&RUN, allow researchers to delve deeper into the regulatory mechanisms that govern gene expression, providing a level of understanding that transcriptional profiling cannot match.
In the GEN eBook, How Epigenomics is Transforming Drug Discovery and Development, readers will explore how epigenomic insights enhance each stage of the drug discovery process, from target identification and validation to mechanism-of-action studies and therapeutic optimization. This eBook reveals why comprehending gene regulation is vital in drug discovery and development, how epigenomic profiling is employed to uncover novel therapeutic targets, decipher drug mechanisms of action, explore treatment resistance, and facilitate the creation of cutting-edge modalities like targeted protein degraders (e.g., PROTACs, molecular glues).
Through next-generation technologies, including CUT&RUN, the eBook offers unprecedented insights into gene regulation. Featuring expert insights and real-world case studies, it illustrates how researchers utilize epigenomic approaches to address critical biological questions, evaluate therapeutic responses, and make informed decisions during drug development.
Whether you're involved in target discovery, translational research, or therapeutic development, this eBook provides a practical guide to the technologies and strategies reshaping modern drug discovery. Discover how CUT&RUN and comparable epigenomic tools assist pharmaceutical and biotechnology researchers in deciphering disease mechanisms, pinpointing high-confidence drug targets, and hastening the creation of more effective therapies.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
